• Home
  • Marc Philippe Wolf
Marc Philippe Wolf

Marc Philippe Wolf

About

17
Publications
7,869
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
1,627
Citations
Introduction
Nanocarriers for therapy of atherosclerosis.
Additional affiliations
July 2007 - present
Universitätsspital Basel
Position
  • Researcher

Publications

Publications (17)
Article
Nanomaterials allow designing targeted therapies, facilitate molecular diagnostics, and are therefore enabling platforms for personalized medicine. A systematic science and a predictive understanding of molecular/supramolecular structure relationships and nanoparticle structure/biological property relationships are needed for rational design and cl...
Article
Full-text available
The pathobiology of atherosclerosis and its current and potential future treatments are summarized, with a spotlight on three central cell types involved: (i) endothelial cells (ECs), (ii) macrophages, and (iii) vascular smooth muscle cells (VSMCs). (i) EC behaviour is regulated by the central transcription factors YAP/TAZ in reaction to biomechani...
Preprint
div>Nanomaterials are suitable for numerous applications in medicine. Building on their design versatility, they enable construction of novel targeted therapies, including personalized medicine. However, the freedom of design entails a multitude of parameters, which have to be optimized for application in nanomedicine. Currently,nonamaterial asso...
Article
We introduce a method to monitor the integrity of micellar nanocarriers using a novel fluorescent dye, IR-780-PDMS and Förster resonance energy transfer (FRET) as a readout. In addition, these dye-loaded nanocarriers can be used as a phototoxic agent in vitro. Mainly, a nanocarrier was designed, based on a previously described amphiphilic ABA-copol...
Article
Full-text available
Cationic polymers as non-viral gene delivery carriers are widely used because of their strong condensing properties and long-term safety, but acute cytotoxicity is a persistent challenge. In this study, two types of polyplexes were prepared by co-formulating plasmid DNA and two cationic diblock copolymers PABOXA5-b-PMOXA33-PA (primary amine) and PA...
Article
Full-text available
Polymeric microfluidic systems are well suited for miniaturized devices with complex functionality, and rapid prototyping methods for 3D microfluidic structures are increasingly used. Mixing at the microscale and performing chemical reactions at the microscale are important applications of such systems and we therefore explored feasibility, mixing...
Article
Full-text available
Microfluidic systems represent a key-enabling platform for novel diagnostic tools for use at the point-of-care in clinical contexts as well as for evolving single cell diagnostics. The design of 3D microfluidic systems is an active field of development, but construction of true interconnected 3D microfluidic networks is still a challenge, in partic...
Article
Full-text available
Existing mouse artery ex vivo perfusion models have utilized arteries such as carotid, uterine, and mesenteric arteries, but not the aorta. However, the aorta is the principal vessel analyzed for atherosclerosis studies in vivo. We have devised a mouse aorta ex vivo perfusion model that can bridge this gap. Aortas from apoE((-/-)) mice are embedded...
Article
Within the last decade, nanotechnology has had a major impact on preclinical development in medicine, shaping the emerging scientific field of nanomedicine. Diverse nanomaterial platforms have been introduced as a carrier systems for the delivery of a variety of payloads (e.g. drugs, proteins, peptides, nucleic acids) but additional improvement by...
Article
This report presents a general method for screening cell surface receptors using so-called micromosaic immunoassays. This method employs a microfluidic chip having n (n = 11) independent flow paths to move cells over m (m = 11) lines of surface-patterned antibodies for screening individual cells in a parallel, combinatorial, fast and flexible manne...
Article
Microfluidics are emerging as a promising technology for miniaturizing biological assays for applications in diagnostics and research in life sciences because they enable the parallel analysis of multiple analytes with economy of samples and in short time. We have previously developed microfluidic networks for surface immunoassays where antibodies...
Article
We show a proof-of-concept in which we combine our previously published concepts of micromosaic immunoassays (microMIAs) with self-regulating microfluidic networks (microFNs) to detect C-reactive protein (CRP) and other cardiac markers such as myoglobin (Mb) and cardiac Troponin I (cTnI). The microFNs are microfabricated in Si, have a well-defined...
Article
Full-text available
The transport of minute amounts of liquids using microfluidic systems has opened avenues for higher throughput and parallelization of miniaturized bio/chemical processes combined with a great economy of reagents. In this report, we present a microfluidic capillary system (CS) that autonomously transports aliquots of different liquids in sequence: l...

Questions

Question (1)
Question
Hi
I am using THP-1 cells. I differentiate them into M1 and M2 macrophages:
1) THP-1 & PMA 80 nM; for 24h -> M0
2) Medium exchange
3) IL-4, IL-13 -> M2 / LPS, IFN-gamma -> M1; both for 24h
4) Medium exchange
5) Fluorescently labeled nanocarriers 24h
6) Wash and flow cytometry measurement
In the FCS/SSC scatter plots I get two populations. I don't know what they correspond to. Apparently, they have different size/granularity (they also show different uptake of the ligand-decorated nanocarriers).
Any comments highly appreciated.

Network

Cited By